Respiratory Pathogen Panel with SARS-CoV-2

Message

Because of current limited supply of test reagent kits, this test is limited to:

Hospital Inpatients
Emergency Room Admit patients
Staff with symptoms and PUI/COVID contact

The Quest "COVID19" test is also available for ER patients not being admitted, turn around time 3-4 days.

Test Code

RVPNLS

Includes

Adenovirus
Coronavirus 229E
Coronavirus HKU1
Coronavirus NL63
Coronavirus OC43
SARS-CoV-2 (COVID 19)
Human Metapneumovirus
Human Rhinovirus/Enterovirus
Influenza A
Influenza A, H1
Influenza A, H1N1
Influenza A, H3
Influenza B
Parainfluenza Virus 1
Parainfluenza Virus 2
Parainfluenza Virus 3
Parainfluenza Virus 4
Respiratory Syncytial Virus
Bordetella pertussis
Chlamydia pneumoniae
Mycoplasma pneumoniae

Preferred Specimen

Nasopharyngeal (NP) Swab in UTM viral transport media

Patient Preparation
1. Follow AHC personal protective policy, gown, glove, and use face protection when collecting specimen.
2. Collect Nasopharyngeal Swab (calcium alginate swabs or cotton swabs with a wooden shaft may not be used),

Gently insert the swab into the nostril. Keep the swab near the septum floor of the nose while gently pushing the swab into the post nasopharynx
As a visual reference, the swab should be inserted about half the distance from the opening of the patient’s nostril and the ear. Rotate the swab several times.

3. Place the swab in Universal Transport Medium (UTM, red top). Break the swab shaft at the score-line against the side of the tube. Note: the swab can alternatively be placed in Viral Culture Media (VCM, green top) for transport.
4. Label specimen per hospital policy.
5. Hand deliver the sample to the lab.

Minimum Volume

1 swab

Transport Container

UTM viral transport media (red top) or VCM viral culture media (green top)

Specimen Stability

Room temperature: 4 hours; Refrigerated: 3 days

Methodology
PCR amplification

Reference Range

Not detected

Clinical Significance

The detection and identification of specific viral and bacterial nucleic acids from individuals presenting with signs and symptoms of a respiratory infection aids in the diagnosis of respiratory infection if used in conjunction with other clinical and epidemiological information.

The results of this test should not be used as the sole basis for diagnosis, treatment or other management decisions. Negative results in the setting of a respiratory illness may be due to infection with pathogens that are not detected by the test or lower respiratory tract infection that is not detected by a nasopharyngeal swab specimen. Positive results do not rule out coinfection with other organisms: the agent(s) detected by the QIAstat-Dx RP SARS-CoV-2 may not be the definite cause of disease. Additional laboratory testing (e.g., bacterial and viral culture, immunofluorescence and radiography) may be necessary when evaluating a patient with possible respiratory tract infection.

The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.